These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8825859)

  • 21. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
    Ferguson M; Heath A
    Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulin.
    Gross S; Janssen SW; de Vries B; Terao E; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):11-25. PubMed ID: 20144449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A collaborative study of the histopathological evaluation of the WHO neurovirulence test for poliovirus vaccines.
    Wood DJ; Heath AB; Marsden SA
    Biologicals; 1994 Mar; 22(1):45-51. PubMed ID: 8068313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative study for the establishment of two European Pharmacopoeia Biological Reference Preparations for serological potency testing of tetanus vaccines for veterinary use.
    Lensing HH; Behr-Gross ME; Daas A; Spieser JM
    Dev Biol (Basel); 2002; 111():69-76. PubMed ID: 12678226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency test of killed polio vaccines. Statistical analysis of test on chicken and preliminary results in combination with ELISA D-antigen determinations.
    Larbaigt G; Moulin J; Souvras M; Gibelin N; Beranger G
    Dev Biol Stand; 1981; 47():113-8. PubMed ID: 6262141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models.
    Shams H; Heron I
    Biologicals; 1999 Sep; 27(3):227-40. PubMed ID: 10652178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains.
    Tano Y; Shimizu H; Martin J; Nishimura Y; Simizu B; Miyamura T
    Vaccine; 2007 Oct; 25(41):7041-6. PubMed ID: 17825459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Swedish inactivated polio vaccine: laboratory standardization and clinical experience over a 30-year period.
    Böttiger M; Larsson B
    Biologicals; 1992 Dec; 20(4):267-75. PubMed ID: 1305403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparisons of poliovirus antigen measurements in vitro and in small animals.
    von Seefried A; Bryce E; Campbell JB; Chun JH; Laurence GD; Scollard N; Tsai KS
    Dev Biol Stand; 1981; 47():91-100. PubMed ID: 6262165
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of an in vivo assay for inactivated polio vaccine.
    Heath AB
    Dev Biol (Basel); 2002; 107():95-104. PubMed ID: 12079197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
    Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
    J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of inactivated poliovirus vaccine derived from Sabin strains.
    Simizu B; Abe S; Yamamoto H; Tano Y; Ota Y; Miyazawa M; Horie H; Satoh K; Wakabayashi K
    Biologicals; 2006 Jun; 34(2):151-4. PubMed ID: 16679028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antigenicity determination of inactivated poliovirus--the micro-neutralization inhibition test].
    Jiang SD; Pye D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Aug; 7(4):309-12. PubMed ID: 3011295
    [No Abstract]   [Full Text] [Related]  

  • 40. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.